These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 29783483)

  • 21. Moral Duties of Genomics Researchers: Why Personalized Medicine Requires a Collective Approach.
    Vos S; van Delden JJM; van Diest PJ; Bredenoord AL
    Trends Genet; 2017 Feb; 33(2):118-128. PubMed ID: 28017398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genitourinary cancers: molecular determinants for personalized therapies.
    Mazzucchelli R; Gasparrini S; Galosi AB; Massari F; Raspollini MR; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
    Urologia; 2016 Sep; 83(3):107-109. PubMed ID: 27338983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-genome sequencing in personalized therapeutics.
    Cordero P; Ashley EA
    Clin Pharmacol Ther; 2012 Jun; 91(6):1001-9. PubMed ID: 22549284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A road toward better education in personalized medicine at universities and beyond.
    Karlikova M; Polivka J; Strojil J; Topolcan O
    Per Med; 2015 Jun; 12(3):259-267. PubMed ID: 29771646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
    Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
    Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic sequencing and precision medicine in head and neck cancers.
    Hoesli RC; Ludwig ML; Michmerhuizen NL; Rosko AJ; Spector ME; Brenner JC; Birkeland AC
    Eur J Surg Oncol; 2017 May; 43(5):884-892. PubMed ID: 28034498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical practice on the horizon: personalized medicine.
    Chadwell K
    Clin Nurse Spec; 2013; 27(1):36-43. PubMed ID: 23222027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics and personalized medicine: the plunge into next-generation sequencing.
    Wadelius M; Alfirevic A
    Genome Med; 2011 Dec; 3(12):78. PubMed ID: 22204519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safe and effective medicines for all: is personalized medicine the answer?
    Cascorbi I
    Expert Rev Clin Pharmacol; 2010 Sep; 3(5):627-37. PubMed ID: 22111745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A revolution in healthcare: challenges and opportunities for personalized medicine.
    Lehrach H;
    Per Med; 2012 Mar; 9(2):105-108. PubMed ID: 29758807
    [No Abstract]   [Full Text] [Related]  

  • 34. Physician liability: the next big thing for personalized medicine?
    Marchant GE; Campos-Outcalt DE; Lindor RA
    Per Med; 2011 Jul; 8(4):457-467. PubMed ID: 29783333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
    Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
    Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in personalized lung cancer medicine.
    Okimoto RA; Bivona TG
    Per Med; 2014; 11(3):309-321. PubMed ID: 25506379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized medicine - the promised land: are we there yet?
    Li C
    Clin Genet; 2011 May; 79(5):403-12. PubMed ID: 21204795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing patient readiness for the clinical adoption of personalized medicine.
    Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
    Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Benefits of Whole-Genome Sequencing Now and in the Future.
    Khromykh A; Solomon BD
    Mol Syndromol; 2015 Sep; 6(3):108-9. PubMed ID: 26778943
    [No Abstract]   [Full Text] [Related]  

  • 40. Next Generation Sequencing: The Next Iteration of Personalized Medicine: Next generation sequencing, along with expanding databases like The Cancer Genome Atlas, has the potential to aid rational drug discovery and streamline clinical trials.
    Carlson B
    Biotechnol Healthc; 2012; 9(2):21-5. PubMed ID: 22876210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.